Hereditary Cancers

The genetic test for hereditary cancers is a specialized analysis that detects mutations in genes which increase the risk of developing various types of cancer. The Comprehensive Hereditary Cancer Panel (Category 2) examines genes associated with inherited cancer forms, enabling early diagnosis, personalized prevention, and targeted treatment.

Types of Cancer Analyzed

• Hereditary Colorectal Cancer:
  Genes: MLH1, MSH2, MSH6, PMS2, APC, MUTYH
• Breast & Ovarian Cancer:
  Genes: BRCA1, BRCA2, PALB2, CHEK2, ATM
• Pancreatic Cancer:
  Genes: BRCA2, CDKN2A, STK11
• Prostate Cancer:
  Genes: BRCA2, HOXB13
• Stomach Cancer:
  Gene: CDH1
• Kidney Cancer:
  Genes: FH, VHL
• Melanoma:
  Genes: CDKN2A, BAP1

Advantages of Genetic Testing

• Early Diagnosis & Personalized Prevention:
  Allows individuals at high risk to receive timely interventions.
• Family Risk Information:
  Informs relatives who may also be at increased risk.
• Tailored Treatments & Medical Interventions:
  Facilitates personalized therapy and adjustments to treatment plans.

The genetic test for hereditary cancer is a valuable tool for preventing and improving health outcomes in individuals with a family history of cancer.